Boston Biomedical Research Institute

Boston Biomedical Research Institute (BBRI) was a non-profit institution concentrating on basic biomedical research to promote the understanding of human diseases (including heart disease, cancer, muscular dystrophy and Alzheimer's etc.). It was located in Watertown, Massachusetts.

History

BBRI was founded in the late 1960s, and relied on federal money to fund most of its research.[1] In 2008 it received a grant to establish a muscular dystrophy research center.[2]

In 2012, reports surfaced that the Institute was financially unsustainable. In the face of a shrinking endowment and decrease of NIH funds, the BBRI Board of Trustees recommended in September, 2012 that the Institute begin a dissolution process. It was also revealed that the institute's funding situation was further hurt when four senior scientists who had significant NIH funding decided to leave BBRI.[3] Members of the Institute's Corporation met on November 15, 2012 and voted to begin the process of closing the Institute.[4]

As of early 2013, the research institute was still in the process of winding down operations. BBRI was also negotiating with Tufts HMO to sell its 1.3 acre property in Watertown, Massachusetts. The proceeds of the sale would be used to pay off some of the organization's creditors.[5]

Timeline

Faculty

References

  1. Ledford, Heidi (20 November 2012). "Private labs caught in budget crunch". Nature. Retrieved 27 September 2013.
  2. "Boston Biomedical to found MD research center". Boston Business Journal. September 22, 2008. Retrieved 9 December 2009.
  3. Cataneo, Emily (1 December 2012). "Watertown research institute to close". Watertown Tab. Retrieved 27 September 2013.
  4. "Research institute in Watertown on verge of closing". Boston Globe. November 12, 2012.
  5. Seiffert, Don (27 February 2013). "Boston Biomedical in talks to sell Watertown site to Tufts HMO". Boston Business Journal. Retrieved 27 September 2013.

External links

This article is issued from Wikipedia - version of the 5/6/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.